Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ

Detalles Bibliográficos
Autores principales: Douxfils, Jonathan, Gillot, Constant, Mullier, François, Favresse, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364678/
https://www.ncbi.nlm.nih.gov/pubmed/34407421
http://dx.doi.org/10.1016/j.jinf.2021.08.023
_version_ 1783738564928864256
author Douxfils, Jonathan
Gillot, Constant
Mullier, François
Favresse, Julien
author_facet Douxfils, Jonathan
Gillot, Constant
Mullier, François
Favresse, Julien
author_sort Douxfils, Jonathan
collection PubMed
description
format Online
Article
Text
id pubmed-8364678
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83646782021-08-15 Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ Douxfils, Jonathan Gillot, Constant Mullier, François Favresse, Julien J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-10 2021-08-15 /pmc/articles/PMC8364678/ /pubmed/34407421 http://dx.doi.org/10.1016/j.jinf.2021.08.023 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Douxfils, Jonathan
Gillot, Constant
Mullier, François
Favresse, Julien
Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title_full Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title_fullStr Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title_full_unstemmed Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title_short Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
title_sort post-sars-cov-2 vaccination specific antibody decrease — thresholds for determining seroprevalence and seroneutralization differ
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364678/
https://www.ncbi.nlm.nih.gov/pubmed/34407421
http://dx.doi.org/10.1016/j.jinf.2021.08.023
work_keys_str_mv AT douxfilsjonathan postsarscov2vaccinationspecificantibodydecreasethresholdsfordeterminingseroprevalenceandseroneutralizationdiffer
AT gillotconstant postsarscov2vaccinationspecificantibodydecreasethresholdsfordeterminingseroprevalenceandseroneutralizationdiffer
AT mullierfrancois postsarscov2vaccinationspecificantibodydecreasethresholdsfordeterminingseroprevalenceandseroneutralizationdiffer
AT favressejulien postsarscov2vaccinationspecificantibodydecreasethresholdsfordeterminingseroprevalenceandseroneutralizationdiffer

Ejemplares similares